for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cooper Companies Inc

COO.N

Latest Trade

302.32USD

Change

1.07(+0.36%)

Volume

165,514

Today's Range

301.36

 - 

306.04

52 Week Range

228.91

 - 

344.19

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
301.25
Open
301.71
Volume
165,514
3M AVG Volume
6.31
Today's High
306.04
Today's Low
301.36
52 Week High
344.19
52 Week Low
228.91
Shares Out (MIL)
49.57
Market Cap (MIL)
14,934.05
Forward P/E
24.46
Dividend (Yield %)
0.02

Next Event

Q4 2019 Cooper Companies Inc Earnings Release

Latest Developments

More

Coopercompanies Announces Q3 Non-Gaap Earnings Per Share $3.23

Cooper Companies Reports Q2 Earnings Per Share Of $2.45

The Cooper Companies Announces First Quarter 2019 Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cooper Companies Inc

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision services three primary regions: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in various modalities. CooperVision's products are primarily manufactured at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and New York. CooperSurgical offers an array of products and services focused on advancing the health of families through a portfolio of products and services focusing on women's health, fertility and diagnostics.

Industry

Medical Equipment & Supplies

Contact Info

6140 Stoneridge Mall Rd Ste 590

+1.925.4603600

http://www.coopercos.com/

Executive Leadership

A. Thomas Bender

Independent Chairman of the Board

Albert G. White

President, Chief Executive Officer, Director

Allan E. Rubenstein

Independent Vice Chairman of the Board, Lead Director

Brian G. Andrews

Chief Financial Officer, Senior Vice President, Treasurer

Robert D. Auerbach

President - CooperSurgical

Key Stats

1.80 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

2.0K

2017

2.1K

2018

2.5K

2019(E)

2.6K
EPS (USD)

2016

8.440

2017

9.700

2018

11.500

2019(E)

12.316
Price To Earnings (TTM)
32.34
Price To Sales (TTM)
5.71
Price To Book (MRQ)
4.13
Price To Cash Flow (TTM)
20.05
Total Debt To Equity (MRQ)
50.14
LT Debt To Equity (MRQ)
39.35
Return on Investment (TTM)
8.38
Return on Equity (TTM)
7.47

Latest News

BRIEF-Generation Investment Management Reports 5.2 Pct Passive Stake In Cooper Companies As Of April 16

* GENERATION INVESTMENT MANAGEMENT LLP REPORTS 5.2 PERCENT PASSIVE STAKE IN COOPER COMPANIES INC AS OF APRIL 16 - SEC FILING Source text: [https://bit.ly/2r1cVFr] Further company coverage:

BRIEF-Brian Andrews To Succeed Albert White As CFO Of Cooper Companies

* BRIAN ANDREWS TO SUCCEED ALBERT WHITE AS CHIEF FINANCIAL OFFICER OF THE COOPER COMPANIES

CORRECTED-BRIEF-Cooper Companies Acquires Lifeglobal Group

* THE COOPER COMPANIES ACQUIRES THE LIFEGLOBAL GROUP, EXPANDING FERTILITY SOLUTIONS PORTFOLIO

BRIEF-Albert White To Succeed Robert Weiss As CEO Of The Cooper Companies

* ALBERT WHITE TO SUCCEED ROBERT WEISS AS CEO OF THE COOPER COMPANIES

BRIEF-Cooper Q1 Non-Gaap Earnings Per Share $2.79

* Q1 EARNINGS PER SHARE VIEW $2.51 -- THOMSON REUTERS I/B/E/S

BRIEF-Cooper Companies Says CEO Robert Weiss' FY 2017 Total Compensation Was $6.6 Mln

* COOPER COMPANIES INC SAYS CEO ROBERT WEISS' FY 2017 TOTAL COMPENSATION WAS $6.6 MILLION VERSUS $6.5 MILLION IN FY 2016 - SEC FILING Source text: (http://bit.ly/2GGvrtK) Further company coverage:

BRIEF-The Cooper Cos reports Q4 Non-GAAP Earnings Per Share $2.65

* THE COOPER COMPANIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS

BRIEF-The Cooper Companies Acquires Paragon Vision Sciences

* COOPER COMPANIES - DEAL EXPECTED TO BE NEUTRAL TO EPS IN FISCAL 2018 EXCLUDING ONE-TIME CHARGES AND DEAL-RELATED AMORTIZATION Source text for Eikon: Further company coverage:

BRIEF-Cooper companies enters into a five-year, $1.425 billion, senior unsecured term loan agreement​

* On November 1, 2017, entered into a five-year, $1.425 billion, senior unsecured term loan agreement

BRIEF-The Cooper Companies provides update on manufacturing facilities in Puerto Rico

* The Cooper Companies provides update on manufacturing facilities in Puerto Rico

BRIEF-Cooper Companies announces agreement to acquire Paragard® IUD from Teva

* The Cooper Companies announces definitive agreement to acquire Paragard® IUD from Teva

BRIEF-Cooper Companies reports Q3 non-GAAP earnings per share of $2.64

* Q3 earnings per share view $2.58 -- Thomson Reuters I/B/E/S

BRIEF-Cooper Companies Q2 adj earnings per share $2.50

* Q2 revenue $522.4 million versus I/B/E/S view $520.7 million

BRIEF-The Cooper Q1 non-gaap EPS $1.93

* Q1 revenue $499.1 million versus i/b/e/s view $502.2 million

BRIEF-Cooper Companies CEO Robert Weiss' FY 2016 total compensation was $6.51 mln

* CEO Robert Weiss' FY 2016 total compensation $6.51 million versus $5.75 million in FY 2015 - sec filing Source text : http://bit.ly/2kakuYH Further company coverage:

BRIEF-Cooper Companies to acquire Wallace from Smiths Medical for a deal valued at about $168 mln

* Cooper companies - Coopersurgical has acquired Wallace, In-Vitro Fertilization (IVF) segment of Smiths Medical, for a deal of approximately $168 million

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up